• Corpus ID: 8029018

CLINICAL TRIALS EXAMINING CERVICAL BARRIERS AS POTENTIAL METHODS FOR PREVENTION OF HIV AND OTHER SEXUALLY TRANSMITTED INFECTIONS

@inproceedings{Skoler2006CLINICALTE,
  title={CLINICAL TRIALS EXAMINING CERVICAL BARRIERS AS POTENTIAL METHODS FOR PREVENTION OF HIV AND OTHER SEXUALLY TRANSMITTED INFECTIONS},
  author={Stephanie Skoler},
  year={2006}
}
The era of large trials of second-generation microbicide products is upon us. Several late-stage trials testing the efficacy of microbicides to prevent HIV infection have begun within the past two years. With their implementation, complex design and operational issues have emerged that exceed the traditional clinical trial challenges of recruiting participants and maintaining protocol adherence. They also extend beyond vaginal microbicides to relevance for other HIV prevention technologies. 

Figures and Tables from this paper

Microbicides for the prevention of HIV infection in women: an overview of recent trials
TLDR
Five broad-spectrum microbicides are now being tested in large-scale effectiveness trials to measure their effects on the reduction of HIV incidence and several challenges that are encountered in the clinical development of microbicide are discussed.
The future of HIV prevention: prospects for an effective anti-HIV microbicide.
Without directly observed sex, what's a microbicide trialist to do? : adherence and adherence measurement as a clinical trial design issue in vaginal microbicide trials for HIV prevention
TLDR
This study demonstrated that trial teams and participants can work together to develop improved trial designs and identify patterns of adherence in microbicide effectiveness trials.
Interim data monitoring to enroll higher-risk participants in HIV prevention trials
TLDR
The on-going modification of recruitment strategies based on the regular analysis of HIV rates appeared to be an efficient method for targeting populations at greatest risk of HIV infection and increasing study power in the Nigeria trial.
Pregnancy Incidence and Correlates in a Clinical Trial Preparedness Study, North West Province South Africa
TLDR
Assessment of incidence and correlates of pregnancy among women at high HIV risk identified new and confirmed existing factors that can facilitate screening for pregnancy risk.
Developing standards of care for HIV prevention research in developing countries – a case study of 10 research centers in Eastern and Southern Africa
TLDR
Ten research centers in East and Southern Africa affiliated with the International AIDS Vaccine Initiative were studied to understand variations, similarities and gaps in services provided, recipients of services, referral systems, and barriers to referral uptake.
New options for barrier contraception.
TLDR
Understanding the use, benefits, and limitations of these barrier methods of birth control will assist women's health care providers to better meet the family planning needs of their patients.
Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
TLDR
It is possible to screen South African women for pregnancy risk at trial entry and providing injectable contraception for free on-site and supporting consistent condom use may reduce incident pregnancy.
Using DHS to Identify Sites for HIV Prevention Trials
TLDR
A latent class model (LCM) was developed, hypothesizing that AIS respondents could be grouped by responses to psychosocial indicators, and that these latent classes would vary by HIV status, socio-demographic, and other indicators.
...
...

References

SHOWING 1-10 OF 36 REFERENCES
Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides
TLDR
Topical microbicides offer women an empowering preventative option but require vigorous testing for safety and effectiveness, and a critical direction of future studies is to identify which assay(s) provide surrogate laboratory markers of safety that correlate with clinical outcomes.
Anti-HIV-1 microbicides -- 'chemical condoms' designed to limit the scourge of the HIV-1 pandemic.
TLDR
This review summarizes some of the important products in the development pipeline of microbicides, self-administered, prophylactic products designed to protect against sexually transmitted pathogens, including HIV-1.
Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
TLDR
Safe and effective topical microbicides are biologically plausible and several trials that are under way may demonstrate the ability of microbicide to protect against transmission of HIV, but multiple challenges remain.
Preclinical studies of alkylureas as anti-HIV-1 contraceptive.
TLDR
The microbicidal system of alkylureas evaluated here lends itself to contraceptive and non-contraceptive anti- HIV-1 formulations and has a wide margin of safety and are spermicidal above their virucidal concentration without any mucosal toxicity.
Microbicides for prevention of transmission of sexually transmitted diseases.
TLDR
Many of the principles of microbicide mechanisms are described and examples of major types ofmicrobicides and their actions are given and put forth the argument for alkyl sulfate microbicides, including sodium dodecyl sulfate (SDS), agents that are in active development in the authors' laboratories.
Integrating behavioral and social science research into microbicide clinical trials: challenges and opportunities.
TLDR
It is found that behavioral and social science research can both support microbicides clinical trial performance and anticipate the information most needed for a rapid and successful introduction of future microbicide products.
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women
TLDR
A 2-week course of 1% tenofovir vaginal gel used twice daily was well tolerated in sexually abstinent and sexually active HIV-negative and HIV-positive women.
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
TLDR
PRO 2000 gel (0.5%) is sufficiently bioavailable and retains substantial antiviral activity after intravaginal application and provides a mechanism for testing the efficacy of a microbicide before embarking on large-scale clinical trials.
A clinician's guide to condoms, spermicides, microbicides, and lubricants
  • P. Jennings, L. Bachmann
  • Medicine, Psychology
    JAAPA : official journal of the American Academy of Physician Assistants
  • 2005
TLDR
The proper use of a new latex condom during every act of sexual intercourse is currently the most effective method of preventing sexually transmitted infections, including HIV.
Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
TLDR
Structural, biological and preclinical studies relevant to the clinical development of these NNRTIs as molecular virucides intended to prevent the sexual transmission of HIV-1 are focused on.
...
...